Thank you for your reply Geordie.
My initial thoughts when PVDM sold a minuscule portion of his holding a short time ago was to financially secure a, at the time, sort after new CEO, among other things and a stake in Biotome may not, in my opinion, have been beyond the realms of possibility. But as you have clarified with their latest SH list, is not the case.
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection, page-98
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $371.1M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 19.5¢ | $1.251M | 6.200M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 1837538 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 114606 | 3 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |